Next-Generation Probiotics: From Traditional Strains to Personalized Therapeutics

Area of Science:

• Microbiome research
• Probiotic development
• Personalized medicine

Background:

• Traditional probiotics (Lactobacillus, Bifidobacterium) support general gut health.
• Next-generation probiotics (NGPs) like Akkermansia muciniphila and Faecalibacterium prausnitzii offer specific functions.
• NGPs are linked to metabolic, inflammatory, and neurological conditions due to targeted mechanisms.

Purpose of the Study:

• Critically compare traditional probiotics and NGPs.
• Highlight mechanistic distinctions and functional advancements of NGPs.
• Explore innovations and challenges in NGP development and application.

Main Methods:

• Review of current microbiome research and probiotic advancements.
• Analysis of mechanistic differences between traditional and next-generation probiotics.
• Examination of synthetic biology, AI, and omics technologies in probiotic therapy.

Main Results:

• NGPs demonstrate targeted functions such as mucin degradation and butyrate production.
• NGPs show potential in modulating host metabolism, inflammation, and immune responses.
• Synthetic biology and AI are enabling personalized probiotic approaches.

Conclusions:

• NGPs represent a significant advancement over traditional probiotics with targeted therapeutic potential.
• Innovations in technology are paving the way for personalized NGP therapies.
• Safety, regulatory, and translational challenges must be addressed for widespread clinical adoption.